Polyelectrolyte-protein synergism: pH-responsive polyelectrolyte/insulin complexes as versatile carriers for targeted protein and drug delivery
Anastasiia Murmiliuk,Hiroki Iwase,Jia-Jhen Kang,Shilpa Mohanakumar,Marie-Sousai Appavou,Kathleen Wood,László Almásy,Adél Len,Kuno Schwärzer,Jürgen Allgaier,Martin Dulle,Thomas Gensch,Beate Förster,Kanae Ito,Hiroshi Nakagawa,Simone Wiegand,Stephan Förster,Aurel Radulescu
DOI: https://doi.org/10.1016/j.jcis.2024.03.156
IF: 9.9
2024-04-01
Journal of Colloid and Interface Science
Abstract:The co-assembly of polyelectrolytes (PE) with proteins offers a promising approach for designing complex structures with customizable morphologies, charge distribution, and stability for targeted cargo delivery. However, the complexity of protein structure limits our ability to predict the properties of the formed nanoparticles, and our goal is to identify the key triggers of the morphological transition in protein/PE complexes and evaluate their ability to encapsulate multivalent ionic drugs. A positively charged PE can assemble with a protein at pH above isoelectric point due to the electrostatic attraction and disassemble at pH below isoelectric point due to the repulsion. The additional hydrophilic block of the polymer should stabilize the particles in solution and enable them to encapsulate a negatively charged drug in the presence of PE excess. We demonstrated that diblock copolymers, poly(ethylene oxide)- block -poly(N,N-dimethylaminoethyl methacrylate) and poly(ethylene oxide)- block -poly(N,N,N-trimethylammonioethyl methacrylate), consisting of a polycation block and a neutral hydrophilic block, reversibly co-assemble with insulin in pH range between 5 and 8. Using small-angle neutron and X-ray scattering (SANS, SAXS), we showed that insulin arrangement within formed particles is controlled by intermolecular electrostatic forces between protein molecules, and can be tuned by varying ionic strength. For the first time, we observed by fluorescence that formed protein/PE complexes with excess of positive charges exhibited potential for encapsulating and controlled release of negatively charged bivalent drugs, protoporphyrin-IX and zinc(II) protoporphyrin-IX, enabling the development of nanocarriers for combination therapies with adjustable charge, stability, internal structure, and size.
chemistry, physical